256 related articles for article (PubMed ID: 32157838)
1. [ACE-inhibition and bradykinin-mediated angioedema].
Ndjekembo Shango D; Simonet O; Vallot F; Defendi F; De Kock M
Rev Med Liege; 2020 Mar; 75(3):151-153. PubMed ID: 32157838
[TBL] [Abstract][Full Text] [Related]
2. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
Fok JS; Katelaris CH; Brown AF; Smith WB
Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
[TBL] [Abstract][Full Text] [Related]
3. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.
Straka BT; Ramirez CE; Byrd JB; Stone E; Woodard-Grice A; Nian H; Yu C; Banerji A; Brown NJ
J Allergy Clin Immunol; 2017 Jul; 140(1):242-248.e2. PubMed ID: 27913306
[TBL] [Abstract][Full Text] [Related]
4. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
Bartal C; Zeldetz V; Stavi V; Barski L
Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
[TBL] [Abstract][Full Text] [Related]
5. [Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors].
Beauchêne C; Martins-Héricher J; Denis D; Martin L; Maillard H
Rev Med Interne; 2018 Oct; 39(10):772-776. PubMed ID: 29735174
[TBL] [Abstract][Full Text] [Related]
6. [Drug-induced angioedema : Focus on bradykinin].
Sachs B; Meier T; Nöthen MM; Stieber C; Stingl J
Hautarzt; 2018 Apr; 69(4):298-305. PubMed ID: 29392343
[TBL] [Abstract][Full Text] [Related]
7. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.
Sinert R; Levy P; Bernstein JA; Body R; Sivilotti MLA; Moellman J; Schranz J; Baptista J; Kimura A; Nothaft W;
J Allergy Clin Immunol Pract; 2017; 5(5):1402-1409.e3. PubMed ID: 28552382
[TBL] [Abstract][Full Text] [Related]
8. Hereditary angioedema: how to approach it at the emergency department?
Serpa FS; Mansour E; Aun MV; Giavina-Bianchi P; Chong Neto HJ; Arruda LK; Campos RA; Motta AA; Toledo E; Grumach AS; Valle SOR
Einstein (Sao Paulo); 2021; 19():eRW5498. PubMed ID: 33852678
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin-mediated angioedema.
Obtułowicz K
Pol Arch Med Wewn; 2016; 126(1-2):76-85. PubMed ID: 26842379
[TBL] [Abstract][Full Text] [Related]
10. Icatibant and ACE inhibitor angioedema.
Illing EJ; Kelly S; Hobson JC; Charters S
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22936825
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
12. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.
Nielsen EW; Gramstad S
Acta Anaesthesiol Scand; 2006 Jan; 50(1):120-2. PubMed ID: 16451161
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
Baş M; Greve J; Stelter K; Havel M; Strassen U; Rotter N; Veit J; Schossow B; Hapfelmeier A; Kehl V; Kojda G; Hoffmann TK
N Engl J Med; 2015 Jan; 372(5):418-25. PubMed ID: 25629740
[TBL] [Abstract][Full Text] [Related]
14. The Angiotensin-Converting-Enzyme-Induced Angioedema.
Bas M
Immunol Allergy Clin North Am; 2017 Feb; 37(1):183-200. PubMed ID: 27886906
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist.
Pucar PA; O'Sullivan M; Goudie A; Marr T; Brusch A
Med J Aust; 2015 Jun; 202(11):596-7. PubMed ID: 26068694
[No Abstract] [Full Text] [Related]
16. [Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options].
Bas M; Kojda G; Stelter K
Anaesthesist; 2011 Dec; 60(12):1141-5. PubMed ID: 20922352
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ACEI-related angioedema with icatibant: a case series.
Bova M; Guilarte M; Sala-Cunill A; Borrelli P; Rizzelli GM; Zanichelli A
Intern Emerg Med; 2015 Apr; 10(3):345-50. PubMed ID: 25666515
[TBL] [Abstract][Full Text] [Related]
18. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
Fast S; Henningsen E; Bygum A
Ugeskr Laeger; 2011 Oct; 173(41):2574-5. PubMed ID: 21985837
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibitor-mediated angioedema.
Montinaro V; Cicardi M
Int Immunopharmacol; 2020 Jan; 78():106081. PubMed ID: 31835086
[TBL] [Abstract][Full Text] [Related]
20. Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age.
Longhurst HJ; Gonçalo M; Godse K; Ensina LF
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2186-2194. PubMed ID: 33819638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
